PGNY Progyny, Inc.

35.71USD+0.73%Mkt Cap: 2.63B USDP/E: 32.76

Progyny, Inc., a benefits management company, provides fertility, family building, and women's health benefits solutions in the United States. It offers fertility benefits solutions, such as differentiated benefits plan …

Insiders, last 90 daysNet sellers
Institutional holders20 on file

Key Statistics

Company
Market Cap2.63B USD
Enterprise Value2.44B USD
Revenue (TTM)1.34B USD
Gross Profit304.48M USD
Net Income (TTM)58.52M USD
Revenue/Share16.71 USD
Last Price35.71 USD
Fiscal Year EndDec 2025
MR QuarterSep 2026
Employees835
CountryUS
SectorHealthcare
IndustryHealthcare Plans
ISIN—
Valuation
P/E (Trailing)32.76
P/E (Forward)14.87
PEG—
EV/EBITDA17.42
EV/Revenue1.82
P/S1.96
P/B6.44
EPS (TTM)1.09 USD
EPS (Forward)2.40 USD
52W Range
16.1093% of range37.20
52W High37.20 USD
52W Low16.10 USD
Profitability
Gross Margin23.63%
Oper. Margin9.97%
EBITDA Margin10.47%
Profit Margin4.54%
ROE11.34%
ROA7.88%
ROIC22.38%
ROCE15.79%
Growth
Revenue Growth8.90%
Earnings Growth113.30%
Cash Flow & Leverage
Operating CF210.19M USD
CapEx (TTM)18.41M USD
FCF Margin14.57%
FCF Yield7.42%
Net Debt-169.73M USD
Net Debt/EBITDA-1.21
Net Debt/FCF-0.87
Balance Sheet
Debt/Equity0.05
Current Ratio1.94
Quick Ratio1.85
Book Value/Sh5.54 USD
Cash/Share2.66 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.4 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)37.75 USD
Upside (mean)+5.7%
Target Range35.00 USD – 42.00 USD
35.00+5.7% to mean42.00
# Analysts12
Ownership
Shares Out.73.65M
Float67.18M
Insiders1.94%
Institutions112.35%
Short Interest
Short Ratio4.9d
Short % Float9.10%
Short % Out.6.37%
Shares Short4.76M
Short (prev mo.)5.09M
Technical
SMA 5029.08 (+22.8%)
SMA 20025.01 (+42.8%)
Beta0.95
S&P 52W Chg12.00%
Avg Vol (30d)1.02M
Avg Vol (10d)1.29M
Technical Indicators
RSI (14)68.1
MACD2.1922
MACD Signal2.1491
MACD Hist.+0.0431
BB Upper40.57 USD
BB Middle33.10 USD
BB Lower25.62 USD
BB Width45.18%
ATR (14)1.115 USD
Vol Ratio (20d)0.91x

About Progyny (NASDAQ: PGNY)

›

Progyny (NASDAQ: PGNY) is listed on Nasdaq, where its shares trade in USD. It belongs to the Healthcare Plans industry, part of the Healthcare sector, and reports about 835 employees.

The shares were at 35.71 USD on 20 November 2026, up 98.3% over 52 weeks. Its 52-week range is 16.10 USD to 37.20 USD: the price is 4.0% below the high and 121.8% above the low.

At a market capitalisation of 2.63B USD, it trades at 32.8 times trailing earnings and 14.9 times forward earnings. The median trailing P/E of its 9 largest Healthcare Plans peers is 19.4, a premium of 69% for PGNY.

Progyny reports return on equity of 11.3%, an operating margin of 10.0% and revenue up 8.9% year over year.

It holds more cash than debt, a net cash position of 169.73M USD. Its Piotroski F-score is 4 out of 9, an average reading of its financial health. 12 analysts cover the stock, with an average rating of Strong Buy; their mean price target of 37.75 USD is 5.7% above the current price. The next earnings report is expected on 25 February 2027.